Copyright © 2015 American Chemical Society
March 9, 2015 Cover
Volume 93, Issue 10
Volume 93, Issue 10
Chemistry is still key to the drug industry’s fortunes
Credit: Shutterstock/Yang/C&EN
» Full Article
March 9, 2015 Issue
Volume 93, Issue 10
March 9, 2015 Issue, Vol. 93 | Iss. 10
Chemistry is still key to the drug industry’s fortunes
(pp. 11-19)
Features
Business
U.S. chemical producers are wobbling a little after an oil price decline but are still on their feet (pp. 27-28)
Science & Technology
3-D bioprinting can already create living tissue, but it’s unclear whether it will ever replicate organs (pp. 37-39)
News of the Week
Helping Brains Relieve Anxiety
Neuroscience: Phosphatase inhibitor restores regulatory circuit
(p.5)Abbvie Wins Pharmacyclics
Pharmaceuticals: $21 billion deal helps firm become a leader in treating blood cancers
(p.6)Climate-Friendly Refrigerants
Regulation: EPA approves five products that have low potentials for global warming
(p.6)Ancient Mars Had Enough Water For A Giant Ocean
New data suggest 20% of Red Planet’s surface was covered by ocean
(p.7)European Chemical Firms Struggle To Secure Growth
Finance: Outlook for 2015 remains uncertain
(p.7)White House Taps Transportation Official To Head Chemical Safety Board
Embattled organization has been beset by management woes, departures
(p.8)AstraZeneca Will Spin Off Antibiotics
Drug Discovery: Stand-alone company to be formed after no buyers emerge for business
(p.9)Computational Models Of Multistep Reaction Are Called So Flawed They Are ‘Not Even Wrong’
Reaction Chemistry: Study reveals mechanism theoretical work didn’t predict
(p.9)Departments
Business
Career oilman reflects on the past four decades and the keys to his company’s success in chemicals
(p.29)
Large firms saw their portfolios hold up against pricing pressures and uneven demand growth
(pp. 23-24)
U.S. chemical producers are wobbling a little after an oil price decline but are still on their feet
(pp. 27-28)
Biotech drug firms saw substantial growth as their big pharma competitors struggled
(pp. 25-26)
Chemistry is still key to the drug industry’s fortunes
(pp. 11-19)Concentrates
(pp. 21-22)
(pp. 21-22)- Mergers Jumped In 2014
- Huntsman Swings Ax At Pigments Again
- Wacker Builds Vinyl Monomers Plant
- Bayer Giveth, Bayer Taketh Away
- Renmatix Gets Total As New Investor
- Biotechs Spar Over Algae
- Patheon Will Acquire API Producer Irix
- American Peptide Goes To Bachem
- Intrexon Gets Maker Of Engineered Apples
- BMS Takes Option On Cancer Vaccine
- Antibiotics Firm Macrolide Launches
- Sun Acquires GSK’s Opiate Operations
- Japan’s JSR Buys U.S. Biologics Maker
- Business Roundup
ACS News
Candidate selections and votes on new international chapters are on the agenda for the spring ACS National Meeting in Denver.
(p.41)Obituaries(pp. 50-51)
(pp. 50-51)
Government & Policy
Tumultuous tenure coming to an end for Rafael Moure-Eraso
(pp. 31-33)
Science & Technology
3-D bioprinting can already create living tissue, but it’s unclear whether it will ever replicate organs
(pp. 37-39)
Instrumentation: Researchers develop the first miniature analyzer for mass spec’s quantitation workhorse
(p.8)Concentrates(pp. 34-35)
(pp. 34-35)